Oral choline tolerance test as a novel noninvasive method for predicting nonalcoholic steatohepatitis
Background Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease, diagnosis using noninvasive methods remains difficult. We previously demonstrated NASH specific impairment of choline metabolism and the...
Saved in:
Published in | Journal of gastroenterology Vol. 49; no. 2; pp. 295 - 304 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Tokyo
Springer Japan
01.02.2014
Springer Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 0944-1174 1435-5922 1435-5922 |
DOI | 10.1007/s00535-013-0776-3 |
Cover
Abstract | Background
Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease, diagnosis using noninvasive methods remains difficult. We previously demonstrated NASH specific impairment of choline metabolism and the use of fasting plasma free choline (fCh) levels for NASH diagnosis. Here, we investigated the utility of an oral choline tolerance test (OCTT), based on disordered choline metabolism, as a novel noninvasive method for NASH diagnosis.
Methods
Sixty-five patients with biopsy proven nonalcoholic fatty liver disease (NAFLD) and 17 healthy controls were enrolled. Blood samples were obtained from all subjects five times during the OCTT (before and 1, 2, 3, and 4 h after oral loading with 260 mg choline).
Results
Four-hour fCh levels after oral loading choline were markedly increased in NASH patients, compared with non-NASH subjects. For detecting NASH, compared with non-NASH subjects, the area under the curve for 4-h fCh levels was 0.829 on receiver operating characteristic (ROC) analysis. The cut-off level for NASH diagnosis was ≥0.16 mg/dL, and the sensitivity, specificity, positive predictive value, and negative predictive value were 80.1, 82.6, 78.4, and 84.4 %, respectively. Moreover, 4-h fCh levels were significantly associated with the disease activity based on NAFLD activity score in patients with NAFLD.
Conclusions
Four-hour fCh levels obtained by an OCTT reflect a NASH specific disorder of choline metabolism, suggesting that the OCTT is a novel and useful noninvasive method for diagnosing NASH at an early stage with sufficient accuracy for clinical practice. |
---|---|
AbstractList | Background
Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease, diagnosis using noninvasive methods remains difficult. We previously demonstrated NASH specific impairment of choline metabolism and the use of fasting plasma free choline (fCh) levels for NASH diagnosis. Here, we investigated the utility of an oral choline tolerance test (OCTT), based on disordered choline metabolism, as a novel noninvasive method for NASH diagnosis.
Methods
Sixty-five patients with biopsy proven nonalcoholic fatty liver disease (NAFLD) and 17 healthy controls were enrolled. Blood samples were obtained from all subjects five times during the OCTT (before and 1, 2, 3, and 4 h after oral loading with 260 mg choline).
Results
Four-hour fCh levels after oral loading choline were markedly increased in NASH patients, compared with non-NASH subjects. For detecting NASH, compared with non-NASH subjects, the area under the curve for 4-h fCh levels was 0.829 on receiver operating characteristic (ROC) analysis. The cut-off level for NASH diagnosis was ≥0.16 mg/dL, and the sensitivity, specificity, positive predictive value, and negative predictive value were 80.1, 82.6, 78.4, and 84.4 %, respectively. Moreover, 4-h fCh levels were significantly associated with the disease activity based on NAFLD activity score in patients with NAFLD.
Conclusions
Four-hour fCh levels obtained by an OCTT reflect a NASH specific disorder of choline metabolism, suggesting that the OCTT is a novel and useful noninvasive method for diagnosing NASH at an early stage with sufficient accuracy for clinical practice. Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease, diagnosis using noninvasive methods remains difficult. We previously demonstrated NASH specific impairment of choline metabolism and the use of fasting plasma free choline (fCh) levels for NASH diagnosis. Here, we investigated the utility of an oral choline tolerance test (OCTT), based on disordered choline metabolism, as a novel noninvasive method for NASH diagnosis.BACKGROUNDAlthough therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease, diagnosis using noninvasive methods remains difficult. We previously demonstrated NASH specific impairment of choline metabolism and the use of fasting plasma free choline (fCh) levels for NASH diagnosis. Here, we investigated the utility of an oral choline tolerance test (OCTT), based on disordered choline metabolism, as a novel noninvasive method for NASH diagnosis.Sixty-five patients with biopsy proven nonalcoholic fatty liver disease (NAFLD) and 17 healthy controls were enrolled. Blood samples were obtained from all subjects five times during the OCTT (before and 1, 2, 3, and 4 h after oral loading with 260 mg choline).METHODSSixty-five patients with biopsy proven nonalcoholic fatty liver disease (NAFLD) and 17 healthy controls were enrolled. Blood samples were obtained from all subjects five times during the OCTT (before and 1, 2, 3, and 4 h after oral loading with 260 mg choline).Four-hour fCh levels after oral loading choline were markedly increased in NASH patients, compared with non-NASH subjects. For detecting NASH, compared with non-NASH subjects, the area under the curve for 4-h fCh levels was 0.829 on receiver operating characteristic (ROC) analysis. The cut-off level for NASH diagnosis was ≥0.16 mg/dL, and the sensitivity, specificity, positive predictive value, and negative predictive value were 80.1, 82.6, 78.4, and 84.4 %, respectively. Moreover, 4-h fCh levels were significantly associated with the disease activity based on NAFLD activity score in patients with NAFLD.RESULTSFour-hour fCh levels after oral loading choline were markedly increased in NASH patients, compared with non-NASH subjects. For detecting NASH, compared with non-NASH subjects, the area under the curve for 4-h fCh levels was 0.829 on receiver operating characteristic (ROC) analysis. The cut-off level for NASH diagnosis was ≥0.16 mg/dL, and the sensitivity, specificity, positive predictive value, and negative predictive value were 80.1, 82.6, 78.4, and 84.4 %, respectively. Moreover, 4-h fCh levels were significantly associated with the disease activity based on NAFLD activity score in patients with NAFLD.Four-hour fCh levels obtained by an OCTT reflect a NASH specific disorder of choline metabolism, suggesting that the OCTT is a novel and useful noninvasive method for diagnosing NASH at an early stage with sufficient accuracy for clinical practice.CONCLUSIONSFour-hour fCh levels obtained by an OCTT reflect a NASH specific disorder of choline metabolism, suggesting that the OCTT is a novel and useful noninvasive method for diagnosing NASH at an early stage with sufficient accuracy for clinical practice. Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease, diagnosis using noninvasive methods remains difficult. We previously demonstrated NASH specific impairment of choline metabolism and the use of fasting plasma free choline (fCh) levels for NASH diagnosis. Here, we investigated the utility of an oral choline tolerance test (OCTT), based on disordered choline metabolism, as a novel noninvasive method for NASH diagnosis. Sixty-five patients with biopsy proven nonalcoholic fatty liver disease (NAFLD) and 17 healthy controls were enrolled. Blood samples were obtained from all subjects five times during the OCTT (before and 1, 2, 3, and 4 h after oral loading with 260 mg choline). Four-hour fCh levels after oral loading choline were markedly increased in NASH patients, compared with non-NASH subjects. For detecting NASH, compared with non-NASH subjects, the area under the curve for 4-h fCh levels was 0.829 on receiver operating characteristic (ROC) analysis. The cut-off level for NASH diagnosis was >=0.16 mg/dL, and the sensitivity, specificity, positive predictive value, and negative predictive value were 80.1, 82.6, 78.4, and 84.4 %, respectively. Moreover, 4-h fCh levels were significantly associated with the disease activity based on NAFLD activity score in patients with NAFLD. Four-hour fCh levels obtained by an OCTT reflect a NASH specific disorder of choline metabolism, suggesting that the OCTT is a novel and useful noninvasive method for diagnosing NASH at an early stage with sufficient accuracy for clinical practice.[PUBLICATION ABSTRACT] Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease, diagnosis using noninvasive methods remains difficult. We previously demonstrated NASH specific impairment of choline metabolism and the use of fasting plasma free choline (fCh) levels for NASH diagnosis. Here, we investigated the utility of an oral choline tolerance test (OCTT), based on disordered choline metabolism, as a novel noninvasive method for NASH diagnosis. Sixty-five patients with biopsy proven nonalcoholic fatty liver disease (NAFLD) and 17 healthy controls were enrolled. Blood samples were obtained from all subjects five times during the OCTT (before and 1, 2, 3, and 4 h after oral loading with 260 mg choline). Four-hour fCh levels after oral loading choline were markedly increased in NASH patients, compared with non-NASH subjects. For detecting NASH, compared with non-NASH subjects, the area under the curve for 4-h fCh levels was 0.829 on receiver operating characteristic (ROC) analysis. The cut-off level for NASH diagnosis was ≥0.16 mg/dL, and the sensitivity, specificity, positive predictive value, and negative predictive value were 80.1, 82.6, 78.4, and 84.4 %, respectively. Moreover, 4-h fCh levels were significantly associated with the disease activity based on NAFLD activity score in patients with NAFLD. Four-hour fCh levels obtained by an OCTT reflect a NASH specific disorder of choline metabolism, suggesting that the OCTT is a novel and useful noninvasive method for diagnosing NASH at an early stage with sufficient accuracy for clinical practice. Background Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease, diagnosis using noninvasive methods remains difficult. We previously demonstrated NASH specific impairment of choline metabolism and the use of fasting plasma free choline (fCh) levels for NASH diagnosis. Here, we investigated the utility of an oral choline tolerance test (OCTT), based on disordered choline metabolism, as a novel noninvasive method for NASH diagnosis. Methods Sixty-five patients with biopsy proven nonalcoholic fatty liver disease (NAFLD) and 17 healthy controls were enrolled. Blood samples were obtained from all subjects five times during the OCTT (before and 1, 2, 3, and 4 h after oral loading with 260 mg choline). Results Four-hour fCh levels after oral loading choline were markedly increased in NASH patients, compared with non-NASH subjects. For detecting NASH, compared with non-NASH subjects, the area under the curve for 4-h fCh levels was 0.829 on receiver operating characteristic (ROC) analysis. The cut-off level for NASH diagnosis was [greater than or equal to]0.16 mg/dL, and the sensitivity, specificity, positive predictive value, and negative predictive value were 80.1, 82.6, 78.4, and 84.4 %, respectively. Moreover, 4-h fCh levels were significantly associated with the disease activity based on NAFLD activity score in patients with NAFLD. Conclusions Four-hour fCh levels obtained by an OCTT reflect a NASH specific disorder of choline metabolism, suggesting that the OCTT is a novel and useful noninvasive method for diagnosing NASH at an early stage with sufficient accuracy for clinical practice. Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease, diagnosis using noninvasive methods remains difficult. We previously demonstrated NASH specific impairment of choline metabolism and the use of fasting plasma free choline (fCh) levels for NASH diagnosis. Here, we investigated the utility of an oral choline tolerance test (OCTT), based on disordered choline metabolism, as a novel noninvasive method for NASH diagnosis. Sixty-five patients with biopsy proven nonalcoholic fatty liver disease (NAFLD) and 17 healthy controls were enrolled. Blood samples were obtained from all subjects five times during the OCTT (before and 1, 2, 3, and 4 h after oral loading with 260 mg choline). Four-hour fCh levels after oral loading choline were markedly increased in NASH patients, compared with non-NASH subjects. For detecting NASH, compared with non-NASH subjects, the area under the curve for 4-h fCh levels was 0.829 on receiver operating characteristic (ROC) analysis. The cut-off level for NASH diagnosis was [greater than or equal to]0.16 mg/dL, and the sensitivity, specificity, positive predictive value, and negative predictive value were 80.1, 82.6, 78.4, and 84.4 %, respectively. Moreover, 4-h fCh levels were significantly associated with the disease activity based on NAFLD activity score in patients with NAFLD. Four-hour fCh levels obtained by an OCTT reflect a NASH specific disorder of choline metabolism, suggesting that the OCTT is a novel and useful noninvasive method for diagnosing NASH at an early stage with sufficient accuracy for clinical practice. |
Audience | Academic |
Author | Saito, Satoru Takahashi, Junichiro Nozaki, Yuichi Fujita, Koji Mawatari, Hironori Imajo, Kento Toshima, Gen Wada, Koichiro Tomeno, Wataru Kessoku, Takaomi Shinohara, Yoshiyasu Ogawa, Yuji Kirikoshi, Hiroyuki Nakajima, Atsushi Yoneda, Masato Sekino, Yusuke Taguri, Masataka |
Author_xml | – sequence: 1 givenname: Kento surname: Imajo fullname: Imajo, Kento organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine – sequence: 2 givenname: Masato surname: Yoneda fullname: Yoneda, Masato organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine – sequence: 3 givenname: Koji surname: Fujita fullname: Fujita, Koji organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine – sequence: 4 givenname: Takaomi surname: Kessoku fullname: Kessoku, Takaomi organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine – sequence: 5 givenname: Wataru surname: Tomeno fullname: Tomeno, Wataru organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine – sequence: 6 givenname: Yuji surname: Ogawa fullname: Ogawa, Yuji organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine – sequence: 7 givenname: Yoshiyasu surname: Shinohara fullname: Shinohara, Yoshiyasu organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine – sequence: 8 givenname: Yusuke surname: Sekino fullname: Sekino, Yusuke organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine – sequence: 9 givenname: Hironori surname: Mawatari fullname: Mawatari, Hironori organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine – sequence: 10 givenname: Yuichi surname: Nozaki fullname: Nozaki, Yuichi organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine – sequence: 11 givenname: Hiroyuki surname: Kirikoshi fullname: Kirikoshi, Hiroyuki organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine – sequence: 12 givenname: Masataka surname: Taguri fullname: Taguri, Masataka organization: Division of Biostatistics and Epidemiology, Yokohama City University Graduate School of Medicine – sequence: 13 givenname: Gen surname: Toshima fullname: Toshima, Gen organization: Skylight Biotech, Inc – sequence: 14 givenname: Junichiro surname: Takahashi fullname: Takahashi, Junichiro organization: Skylight Biotech, Inc – sequence: 15 givenname: Satoru surname: Saito fullname: Saito, Satoru organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine – sequence: 16 givenname: Koichiro surname: Wada fullname: Wada, Koichiro organization: Department of Pharmacology, Graduate School of Dentistry, Osaka University – sequence: 17 givenname: Atsushi surname: Nakajima fullname: Nakajima, Atsushi email: nakajima-tky@umin.ac.jp organization: Division of Gastroenterology, Yokohama City University Graduate School of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23503837$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kV1rVDEQhoNU7Lb6A7yRA954c2o-T3IuS9EqFHqj1yEnmbObkk3WJLvgv2-O2_pRVALJMDzvTGbeM3QSUwSEXhN8QTCW7wvGgokeE9ZjKYeePUMrwltGjJSeoBUeOe8JkfwUnZVyhxuIhXqBTikTmCkmVwhuswmd3aTgI3Q1Bcgm2hZBqZ0pneliOkBod_TxYIo_QLeFukmum1Pudhmct9XH9UKYYNNSyXalgqlpAztTffXlJXo-m1Dg1cN7jr5-_PDl6lN_c3v9-erypreCjrWfmOQWKB-Jm8w4T4Nkwo2gBjwrR5V1MAgjlBKDUlYQgsk4MWGFm6QSdHDsHL071t3l9G3fRtBbXyyEYCKkfdGEjyMRmA-8oW-foHdpn9sIPyhFCeaY_qLWJoD2cU41G7sU1ZeScKE44Qt18ReqHQdbb5tns2_5PwRvHprvpy04vct-a_J3_ehLA8gRsDmVkmH-iRCsF-_10XvdLNWL95o1jXyisb62_afYfuPDf5X0qCytS1xD_m0X_xTdA33UwLY |
CitedBy_id | crossref_primary_10_1371_journal_pone_0115403 crossref_primary_10_33549_physiolres_933784 crossref_primary_10_3390_diagnostics10030129 crossref_primary_10_1002_cpt_66 crossref_primary_10_1016_j_molmet_2024_101874 crossref_primary_10_1016_j_jcmgh_2023_05_010 crossref_primary_10_1016_j_metabol_2016_12_013 crossref_primary_10_1007_s00535_016_1264_3 |
Cites_doi | 10.1007/s00535-007-2060-x 10.1002/hep.22140 10.1007/s00535-007-2014-3 10.1055/s-2001-12925 10.1002/hep.21768 10.1186/1471-230X-8-53 10.7326/0003-4819-143-10-200511150-00009 10.1002/hep.21984 10.1055/s-0028-1091983 10.1002/hep.24376 10.1002/hep.20973 10.1055/s-0028-1091978 10.1002/hep.21327 10.1053/j.gastro.2005.03.084 10.1016/S0016-5085(99)70506-8 10.1111/j.1872-034X.2012.00976.x 10.1111/j.1572-0241.1999.01377.x 10.1111/j.1572-0241.2004.30159.x 10.1146/annurev.nu.14.070194.001413 10.1002/hep.23094 10.1148/radiology.211.1.r99ap15283 10.1002/hep.20223 10.1007/BF00280883 10.1080/13547500500421070 10.1002/hep.21223 10.1053/jhep.2003.50320 10.1002/hep.23050 10.1002/hep.20701 10.1111/j.1440-1746.2006.04447.x 10.2337/diacare.20.7.1183 10.1016/S0022-2275(20)30123-1 |
ContentType | Journal Article |
Copyright | Springer Japan 2013 COPYRIGHT 2014 Springer Springer Japan 2014 |
Copyright_xml | – notice: Springer Japan 2013 – notice: COPYRIGHT 2014 Springer – notice: Springer Japan 2014 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7T5 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU FYUFA GHDGH H94 K9- K9. KB0 M0R M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 |
DOI | 10.1007/s00535-013-0776-3 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts Consumer Health Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Consumer Health Database ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium Proquest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest One Academic Middle East (New) MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1435-5922 |
EndPage | 304 |
ExternalDocumentID | 3219137401 A714584142 23503837 10_1007_s00535_013_0776_3 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 2.D 203 28- 29K 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5VS 67Z 6NX 78A 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ AXYYD AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BKNYI BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP D-I DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IAO IHE IHR IJ- IKXTQ IMOTQ INH IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ K9- KDC KOV KOW KPH LAS LLZTM M0R M1P M4Y MA- N2Q N9A NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P P9S PCD PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 WOW X7M YLTOR Z45 Z7U Z7W Z82 Z83 Z87 Z8O Z8Q Z8V Z8W Z91 ZMTXR ZOVNA ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM AEIIB PMFND 7T5 7XB 8FK ABRTQ H94 K9. PJZUB PKEHL PPXIY PQEST PQUKI 7X8 PUEGO |
ID | FETCH-LOGICAL-c529t-b374ce2491dba9fb6735d9e860f8d28cde65a5885688c511019b35c5db78526d3 |
IEDL.DBID | BENPR |
ISSN | 0944-1174 1435-5922 |
IngestDate | Thu Sep 04 19:55:48 EDT 2025 Fri Aug 15 23:01:33 EDT 2025 Tue Jun 17 21:55:22 EDT 2025 Tue Jun 10 20:14:47 EDT 2025 Thu Apr 03 07:00:54 EDT 2025 Thu Apr 24 23:11:46 EDT 2025 Tue Jul 01 04:34:10 EDT 2025 Fri Feb 21 02:29:32 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | OCTT NAFLD NASH Plasma free choline levels Noninvasive test |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c529t-b374ce2491dba9fb6735d9e860f8d28cde65a5885688c511019b35c5db78526d3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
PMID | 23503837 |
PQID | 1498210402 |
PQPubID | 33411 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1499150464 proquest_journals_1498210402 gale_infotracmisc_A714584142 gale_infotracacademiconefile_A714584142 pubmed_primary_23503837 crossref_primary_10_1007_s00535_013_0776_3 crossref_citationtrail_10_1007_s00535_013_0776_3 springer_journals_10_1007_s00535_013_0776_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-02-01 |
PublicationDateYYYYMMDD | 2014-02-01 |
PublicationDate_xml | – month: 02 year: 2014 text: 2014-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Tokyo |
PublicationPlace_xml | – name: Tokyo – name: Japan |
PublicationTitle | Journal of gastroenterology |
PublicationTitleAbbrev | J Gastroenterol |
PublicationTitleAlternate | J Gastroenterol |
PublicationYear | 2014 |
Publisher | Springer Japan Springer Springer Nature B.V |
Publisher_xml | – name: Springer Japan – name: Springer – name: Springer Nature B.V |
References | Brunt, Janney, Di Bisceglie, Neuschwander-Tetri, Bacon (CR13) 1999; 94 Guha, Parkes, Roderick, Chattopadhyay, Cross, Harris, Kaye (CR6) 2009; 47 Matteoni, Younossi, Gramlich, Boparai, Liu, McCullough (CR11) 1999; 116 (CR16) 1997; 20 Fujita, Nozaki, Wada, Yoneda, Fujimoto, Fujitake, Endo (CR9) 2009; 50 Yoneda, Uchiyama, Kato, Endo, Fujita, Yoneda, Mawatari (CR31) 2008; 8 Farrell, Larter (CR1) 2006; 43 Imajo, Fujita, Yoneda, Shinohara, Suzuki, Mawatari, Takahashi (CR10) 2012; 42 Matthews, Hosker, Rudenski, Naylor, Treacher, Turner (CR15) 1985; 28 Sanyal, Brunt, Kleiner, Kowdley, Chalasani, Lavine (CR18) 2011; 54 Ratziu, Charlotte, Heurtier, Gombert, Giral, Bruckert (CR36) 2005; 128 Guha, Parkes, Roderick, Chattopadhyay, Cross, Harris, Kaye (CR26) 2009; 47 Yoneda, Mawatari, Fujita, Iida, Yonemitsu, Kato, Takahashi (CR30) 2007; 42 Younossi, Gramlich, Liu, Matteoni, Petrelli, Goldblum, Rybicki (CR4) 1998; 11 Ludwig, Viggiano, McGill, Oh (CR22) 1980; 55 Brunt (CR12) 2001; 21 Matteoni, Younossi, Gramlich, Boparani, Liu, McCullough (CR5) 1999; 116 Wieckowska, Zein, Yerian, Lopez, McCullough, Feldstein (CR32) 2006; 44 Feldstein, Wieckowska, Lopez, Liu, Zein, McCullough (CR33) 2009; 50 Hui, Kench, Chitturi, Sud, Farrell, Byth, Hall (CR21) 2003; 38 Yoneda, Mawatari, Fujita, Yonemitsu, Kato, Takahashi, Kirikoshi (CR34) 2007; 42 Ekstedt, Franzen, Mathiesen, Thorelius, Holmqvist, Bodemar, Kechagias (CR24) 2006; 44 Usui, Hara, Hosaki, Okazaki (CR17) 2002; 43 Kaneda, Hashimoto, Yatsuji, Tokushige, Shiratori (CR35) 2006; 21 Hamaguchi, Kojima, Takeda, Nagata, Takeda, Sarui, Kawahito (CR3) 2005; 143 Wieckowska, McCullough, Feldstein (CR25) 2007; 46 Brunt (CR19) 2001; 21 Solga, Alkhuraishe, Cope, Tabesh, Clark, Torbenson, Schwartz (CR28) 2006; 11 Chalasani, Deeg, Crabb (CR27) 2004; 99 Baranova, Younossi (CR7) 2008; 47 Wieckowska, Feldstein (CR8) 2008; 28 Yoshizumi, Nakamura, Yamane, Islam, Menju, Yamasaki, Arai (CR14) 1999; 211 Kleiner, Brunt, Van Natta, Behling, Contos, Cummings, Ferrell (CR20) 2005; 41 Zeisel, Blusztajn (CR23) 1994; 14 Lazo, Clark (CR2) 2008; 28 Hui, Farrell, Kench, George (CR29) 2004; 39 JM Hui (776_CR21) 2003; 38 AJ Sanyal (776_CR18) 2011; 54 V Ratziu (776_CR36) 2005; 128 American Diabetes Association (776_CR16) 1997; 20 SH Zeisel (776_CR23) 1994; 14 M Yoneda (776_CR30) 2007; 42 AE Feldstein (776_CR33) 2009; 50 A Baranova (776_CR7) 2008; 47 A Wieckowska (776_CR32) 2006; 44 M Yoneda (776_CR31) 2008; 8 T Yoshizumi (776_CR14) 1999; 211 ZM Younossi (776_CR4) 1998; 11 M Ekstedt (776_CR24) 2006; 44 M Lazo (776_CR2) 2008; 28 DR Matthews (776_CR15) 1985; 28 DE Kleiner (776_CR20) 2005; 41 N Chalasani (776_CR27) 2004; 99 GC Farrell (776_CR1) 2006; 43 S Usui (776_CR17) 2002; 43 H Kaneda (776_CR35) 2006; 21 M Hamaguchi (776_CR3) 2005; 143 K Imajo (776_CR10) 2012; 42 EM Brunt (776_CR13) 1999; 94 EM Brunt (776_CR19) 2001; 21 SF Solga (776_CR28) 2006; 11 IN Guha (776_CR6) 2009; 47 C Matteoni (776_CR5) 1999; 116 CA Matteoni (776_CR11) 1999; 116 M Yoneda (776_CR34) 2007; 42 IN Guha (776_CR26) 2009; 47 EM Brunt (776_CR12) 2001; 21 A Wieckowska (776_CR25) 2007; 46 JM Hui (776_CR29) 2004; 39 A Wieckowska (776_CR8) 2008; 28 K Fujita (776_CR9) 2009; 50 J Ludwig (776_CR22) 1980; 55 15122781 - Hepatology. 2004 May;39(5):1458-9 15307867 - Am J Gastroenterol. 2004 Aug;99(8):1497-502 17006923 - Hepatology. 2006 Oct;44(4):865-73 21520200 - Hepatology. 2011 Jul;54(1):344-53 16287793 - Ann Intern Med. 2005 Nov 15;143(10 ):722-8 19585618 - Hepatology. 2009 Oct;50(4):1072-8 16799979 - Hepatology. 2006 Jul;44(1):27-33 15940625 - Gastroenterology. 2005 Jun;128(7):1898-906 10189485 - Radiology. 1999 Apr;211(1):283-6 10484010 - Am J Gastroenterol. 1999 Sep;94(9):2467-74 9647594 - Mod Pathol. 1998 Jun;11(6):560-5 19014569 - BMC Gastroenterol. 2008 Nov 14;8:53 15915461 - Hepatology. 2005 Jun;41(6):1313-21 11296695 - Semin Liver Dis. 2001;21(1):3-16 10348825 - Gastroenterology. 1999 Jun;116(6):1413-9 11971952 - J Lipid Res. 2002 May;43(5):805-14 18038452 - Hepatology. 2008 Feb;47(2):455-60 16911693 - J Gastroenterol Hepatol. 2006 Sep;21(9):1459-65 18956290 - Semin Liver Dis. 2008 Nov;28(4):339-50 7946521 - Annu Rev Nutr. 1994;14:269-96 16447287 - Hepatology. 2006 Feb;43(2 Suppl 1):S99-S112 17530362 - J Gastroenterol. 2007 May;42(5):375-81 19650159 - Hepatology. 2009 Sep;50(3):772-80 7382552 - Mayo Clin Proc. 1980 Jul;55(7):434-8 3899825 - Diabetologia. 1985 Jul;28(7):412-9 17653654 - J Gastroenterol. 2007 Jul;42(7):573-82 18956295 - Semin Liver Dis. 2008 Nov;28(4):386-95 9203460 - Diabetes Care. 1997 Jul;20(7):1183-97 17661414 - Hepatology. 2007 Aug;46(2):582-9 12883486 - Hepatology. 2003 Aug;38(2):420-7 22780848 - Hepatol Res. 2012 Aug;42(8):757-66 16766393 - Biomarkers. 2006 Mar-Apr;11(2):174-83 18220279 - Hepatology. 2008 Feb;47(2):373-5 |
References_xml | – volume: 42 start-page: 573 year: 2007 end-page: 582 ident: CR30 article-title: High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH publication-title: J Gastroenterol doi: 10.1007/s00535-007-2060-x – volume: 47 start-page: 373 year: 2008 end-page: 375 ident: CR7 article-title: The future is around the corner: noninvasive diagnosis of the progressive nonalcoholic steatohepatitis publication-title: Hepatology doi: 10.1002/hep.22140 – volume: 42 start-page: 375 year: 2007 end-page: 381 ident: CR34 article-title: Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage publication-title: J Gastroenterol doi: 10.1007/s00535-007-2014-3 – volume: 21 start-page: 3 year: 2001 end-page: 16 ident: CR12 article-title: Nonalcoholic steatohepatitis: definition and pathology publication-title: Semin Liver Dis doi: 10.1055/s-2001-12925 – volume: 46 start-page: 582 year: 2007 end-page: 589 ident: CR25 article-title: Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future publication-title: Hepatology doi: 10.1002/hep.21768 – volume: 8 start-page: 53 year: 2008 end-page: 61 ident: CR31 article-title: Plasma pentraxin 3 is a novel marker for nonalcoholic steatohepatitis (NASH) publication-title: BMC Gastroenterol doi: 10.1186/1471-230X-8-53 – volume: 143 start-page: 722 year: 2005 end-page: 728 ident: CR3 article-title: The metabolic syndrome as a predictor of nonalcoholic fatty liver disease publication-title: Ann Intern Med doi: 10.7326/0003-4819-143-10-200511150-00009 – volume: 55 start-page: 434 year: 1980 end-page: 438 ident: CR22 article-title: Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease publication-title: Mayo Clin Proc – volume: 47 start-page: 455 year: 2009 end-page: 460 ident: CR26 article-title: Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European liver fibrosis panel and exploring simple markers publication-title: Hepatology doi: 10.1002/hep.21984 – volume: 28 start-page: 386 year: 2008 end-page: 395 ident: CR8 article-title: Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive publication-title: Semin Liver Dis doi: 10.1055/s-0028-1091983 – volume: 54 start-page: 344 year: 2011 end-page: 353 ident: CR18 article-title: Endpoints and clinical trial design for nonalcoholic steatohepatitis publication-title: Hepatology doi: 10.1002/hep.24376 – volume: 43 start-page: 99 year: 2006 end-page: 112 ident: CR1 article-title: Nonalcoholic fatty liver disease: from steatosis to cirrhosis publication-title: Hepatology doi: 10.1002/hep.20973 – volume: 28 start-page: 339 year: 2008 end-page: 350 ident: CR2 article-title: The epidemiology of nonalcoholic fatty liver disease: a global perspective publication-title: Semin Liver Dis doi: 10.1055/s-0028-1091978 – volume: 44 start-page: 865 year: 2006 end-page: 873 ident: CR24 article-title: Long-term follow-up of patients with NAFLD and elevated liver enzymes publication-title: Hepatology doi: 10.1002/hep.21327 – volume: 128 start-page: 1898 year: 2005 end-page: 1906 ident: CR36 article-title: Sampling variability of liver biopsy in nonalcoholic fatty liver disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2005.03.084 – volume: 116 start-page: 1413 year: 1999 end-page: 1419 ident: CR5 article-title: A non-alcoholic fatty liver disease: a spectrum of clinical and pathologic severity publication-title: Gastroenterology doi: 10.1016/S0016-5085(99)70506-8 – volume: 42 start-page: 757 year: 2012 end-page: 766 ident: CR10 article-title: Plasma free choline is a novel non-invasive biomarker for early-stage non-alcoholic steatohepatitis: a multi-center validation study publication-title: Hepatol Res doi: 10.1111/j.1872-034X.2012.00976.x – volume: 94 start-page: 2467 year: 1999 end-page: 2474 ident: CR13 article-title: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.1999.01377.x – volume: 11 start-page: 560 year: 1998 end-page: 565 ident: CR4 article-title: Non-alcoholic fatty liver: assessment of variability in the pathologic interpretations publication-title: Mod Pathol – volume: 99 start-page: 1497 year: 2004 end-page: 1502 ident: CR27 article-title: Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2004.30159.x – volume: 43 start-page: 805 year: 2002 end-page: 814 ident: CR17 article-title: A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC publication-title: J Lipid Res – volume: 20 start-page: 1183 year: 1997 end-page: 1197 ident: CR16 article-title: Report of the expert committee on the diagnosis and classification of diabetes mellitus publication-title: Diabetes Care – volume: 14 start-page: 269 year: 1994 end-page: 296 ident: CR23 article-title: Choline and human nutrition publication-title: Annu Rev Nutr doi: 10.1146/annurev.nu.14.070194.001413 – volume: 50 start-page: 772 year: 2009 end-page: 780 ident: CR9 article-title: Dysfunctional very-low density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis publication-title: Hepatology doi: 10.1002/hep.23094 – volume: 211 start-page: 283 year: 1999 end-page: 286 ident: CR14 article-title: Abdominal fat: standardized technique for measurement at CT publication-title: Radiology doi: 10.1148/radiology.211.1.r99ap15283 – volume: 39 start-page: 1458 year: 2004 end-page: 1459 ident: CR29 article-title: High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD publication-title: Hepatology doi: 10.1002/hep.20223 – volume: 47 start-page: 455 year: 2009 end-page: 460 ident: CR6 article-title: Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European liver fibrosis panel and exploring simple markers publication-title: Hepatology doi: 10.1002/hep.21984 – volume: 28 start-page: 412 year: 1985 end-page: 419 ident: CR15 article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man publication-title: Diabetologia doi: 10.1007/BF00280883 – volume: 21 start-page: 3 year: 2001 end-page: 16 ident: CR19 article-title: Nonalcoholic steatohepatitis: definition and pathology publication-title: Semin Liver Dis doi: 10.1055/s-2001-12925 – volume: 11 start-page: 174 year: 2006 end-page: 183 ident: CR28 article-title: Breath biomarkers and non-alcoholic fatty liver disease: preliminary observations publication-title: Biomarkers doi: 10.1080/13547500500421070 – volume: 44 start-page: 27 year: 2006 end-page: 33 ident: CR32 article-title: In vivo assessment of liver cell apoptosis as a novel biomarker of disease sensitivity in nonalcoholic fatty liver disease publication-title: Hepatology doi: 10.1002/hep.21223 – volume: 21 start-page: 1459 year: 2006 end-page: 1465 ident: CR35 article-title: Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease publication-title: J Gastroenterol Hepatol – volume: 38 start-page: 420 year: 2003 end-page: 427 ident: CR21 article-title: Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C publication-title: Hepatology doi: 10.1053/jhep.2003.50320 – volume: 50 start-page: 1072 year: 2009 end-page: 1078 ident: CR33 article-title: Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study publication-title: Hepatology doi: 10.1002/hep.23050 – volume: 41 start-page: 1313 year: 2005 end-page: 1321 ident: CR20 article-title: Design and validation of a histological scoring system for nonalcoholic fatty liver disease publication-title: Hepatology doi: 10.1002/hep.20701 – volume: 116 start-page: 1413 year: 1999 end-page: 1419 ident: CR11 article-title: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity publication-title: Gastroenterology doi: 10.1016/S0016-5085(99)70506-8 – volume: 11 start-page: 174 year: 2006 ident: 776_CR28 publication-title: Biomarkers doi: 10.1080/13547500500421070 – volume: 116 start-page: 1413 year: 1999 ident: 776_CR5 publication-title: Gastroenterology doi: 10.1016/S0016-5085(99)70506-8 – volume: 43 start-page: 99 year: 2006 ident: 776_CR1 publication-title: Hepatology doi: 10.1002/hep.20973 – volume: 21 start-page: 3 year: 2001 ident: 776_CR19 publication-title: Semin Liver Dis doi: 10.1055/s-2001-12925 – volume: 47 start-page: 455 year: 2009 ident: 776_CR26 publication-title: Hepatology doi: 10.1002/hep.21984 – volume: 116 start-page: 1413 year: 1999 ident: 776_CR11 publication-title: Gastroenterology doi: 10.1016/S0016-5085(99)70506-8 – volume: 94 start-page: 2467 year: 1999 ident: 776_CR13 publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.1999.01377.x – volume: 21 start-page: 3 year: 2001 ident: 776_CR12 publication-title: Semin Liver Dis doi: 10.1055/s-2001-12925 – volume: 44 start-page: 865 year: 2006 ident: 776_CR24 publication-title: Hepatology doi: 10.1002/hep.21327 – volume: 44 start-page: 27 year: 2006 ident: 776_CR32 publication-title: Hepatology doi: 10.1002/hep.21223 – volume: 46 start-page: 582 year: 2007 ident: 776_CR25 publication-title: Hepatology doi: 10.1002/hep.21768 – volume: 55 start-page: 434 year: 1980 ident: 776_CR22 publication-title: Mayo Clin Proc – volume: 21 start-page: 1459 year: 2006 ident: 776_CR35 publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2006.04447.x – volume: 47 start-page: 373 year: 2008 ident: 776_CR7 publication-title: Hepatology doi: 10.1002/hep.22140 – volume: 50 start-page: 772 year: 2009 ident: 776_CR9 publication-title: Hepatology doi: 10.1002/hep.23094 – volume: 47 start-page: 455 year: 2009 ident: 776_CR6 publication-title: Hepatology doi: 10.1002/hep.21984 – volume: 128 start-page: 1898 year: 2005 ident: 776_CR36 publication-title: Gastroenterology doi: 10.1053/j.gastro.2005.03.084 – volume: 38 start-page: 420 year: 2003 ident: 776_CR21 publication-title: Hepatology – volume: 211 start-page: 283 year: 1999 ident: 776_CR14 publication-title: Radiology doi: 10.1148/radiology.211.1.r99ap15283 – volume: 8 start-page: 53 year: 2008 ident: 776_CR31 publication-title: BMC Gastroenterol doi: 10.1186/1471-230X-8-53 – volume: 41 start-page: 1313 year: 2005 ident: 776_CR20 publication-title: Hepatology doi: 10.1002/hep.20701 – volume: 28 start-page: 412 year: 1985 ident: 776_CR15 publication-title: Diabetologia doi: 10.1007/BF00280883 – volume: 42 start-page: 757 year: 2012 ident: 776_CR10 publication-title: Hepatol Res doi: 10.1111/j.1872-034X.2012.00976.x – volume: 20 start-page: 1183 year: 1997 ident: 776_CR16 publication-title: Diabetes Care doi: 10.2337/diacare.20.7.1183 – volume: 14 start-page: 269 year: 1994 ident: 776_CR23 publication-title: Annu Rev Nutr doi: 10.1146/annurev.nu.14.070194.001413 – volume: 42 start-page: 573 year: 2007 ident: 776_CR30 publication-title: J Gastroenterol doi: 10.1007/s00535-007-2060-x – volume: 39 start-page: 1458 year: 2004 ident: 776_CR29 publication-title: Hepatology doi: 10.1002/hep.20223 – volume: 43 start-page: 805 year: 2002 ident: 776_CR17 publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)30123-1 – volume: 54 start-page: 344 year: 2011 ident: 776_CR18 publication-title: Hepatology doi: 10.1002/hep.24376 – volume: 42 start-page: 375 year: 2007 ident: 776_CR34 publication-title: J Gastroenterol doi: 10.1007/s00535-007-2014-3 – volume: 143 start-page: 722 year: 2005 ident: 776_CR3 publication-title: Ann Intern Med doi: 10.7326/0003-4819-143-10-200511150-00009 – volume: 50 start-page: 1072 year: 2009 ident: 776_CR33 publication-title: Hepatology doi: 10.1002/hep.23050 – volume: 28 start-page: 339 year: 2008 ident: 776_CR2 publication-title: Semin Liver Dis doi: 10.1055/s-0028-1091978 – volume: 99 start-page: 1497 year: 2004 ident: 776_CR27 publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2004.30159.x – volume: 28 start-page: 386 year: 2008 ident: 776_CR8 publication-title: Semin Liver Dis doi: 10.1055/s-0028-1091983 – volume: 11 start-page: 560 year: 1998 ident: 776_CR4 publication-title: Mod Pathol – reference: 19585618 - Hepatology. 2009 Oct;50(4):1072-8 – reference: 16766393 - Biomarkers. 2006 Mar-Apr;11(2):174-83 – reference: 22780848 - Hepatol Res. 2012 Aug;42(8):757-66 – reference: 15940625 - Gastroenterology. 2005 Jun;128(7):1898-906 – reference: 18956290 - Semin Liver Dis. 2008 Nov;28(4):339-50 – reference: 7946521 - Annu Rev Nutr. 1994;14:269-96 – reference: 11971952 - J Lipid Res. 2002 May;43(5):805-14 – reference: 11296695 - Semin Liver Dis. 2001;21(1):3-16 – reference: 15915461 - Hepatology. 2005 Jun;41(6):1313-21 – reference: 10189485 - Radiology. 1999 Apr;211(1):283-6 – reference: 15122781 - Hepatology. 2004 May;39(5):1458-9 – reference: 10348825 - Gastroenterology. 1999 Jun;116(6):1413-9 – reference: 15307867 - Am J Gastroenterol. 2004 Aug;99(8):1497-502 – reference: 7382552 - Mayo Clin Proc. 1980 Jul;55(7):434-8 – reference: 16911693 - J Gastroenterol Hepatol. 2006 Sep;21(9):1459-65 – reference: 12883486 - Hepatology. 2003 Aug;38(2):420-7 – reference: 19650159 - Hepatology. 2009 Sep;50(3):772-80 – reference: 10484010 - Am J Gastroenterol. 1999 Sep;94(9):2467-74 – reference: 17530362 - J Gastroenterol. 2007 May;42(5):375-81 – reference: 9203460 - Diabetes Care. 1997 Jul;20(7):1183-97 – reference: 16799979 - Hepatology. 2006 Jul;44(1):27-33 – reference: 9647594 - Mod Pathol. 1998 Jun;11(6):560-5 – reference: 18220279 - Hepatology. 2008 Feb;47(2):373-5 – reference: 16447287 - Hepatology. 2006 Feb;43(2 Suppl 1):S99-S112 – reference: 16287793 - Ann Intern Med. 2005 Nov 15;143(10 ):722-8 – reference: 18038452 - Hepatology. 2008 Feb;47(2):455-60 – reference: 17006923 - Hepatology. 2006 Oct;44(4):865-73 – reference: 3899825 - Diabetologia. 1985 Jul;28(7):412-9 – reference: 17653654 - J Gastroenterol. 2007 Jul;42(7):573-82 – reference: 19014569 - BMC Gastroenterol. 2008 Nov 14;8:53 – reference: 21520200 - Hepatology. 2011 Jul;54(1):344-53 – reference: 17661414 - Hepatology. 2007 Aug;46(2):582-9 – reference: 18956295 - Semin Liver Dis. 2008 Nov;28(4):386-95 |
SSID | ssj0013058 |
Score | 2.109596 |
Snippet | Background
Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the... Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the disease,... Background Although therapeutic intervention for nonalcoholic steatohepatitis (NASH) at an early stage is important owing to the progressive nature of the... |
SourceID | proquest gale pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 295 |
SubjectTerms | Abdominal Surgery Administration, Oral Adult Aged Area Under Curve Biliary Tract Case-Control Studies Choline Choline - administration & dosage Choline - blood Colorectal Surgery Ethylenediaminetetraacetic acid Evaluation Fasting Fatty Liver - blood Fatty Liver - diagnosis Female Fibrosis Gastroenterology Health aspects Hepatology Humans Lipoproteins, VLDL - blood Lipotropic Agents - administration & dosage Lipotropic Agents - blood Liver Liver - pathology Liver diseases Male Medical colleges Medicine Medicine & Public Health Methods Middle Aged Non-alcoholic Fatty Liver Disease Original Article—Liver Pancreas Physiological aspects Predictive Value of Tests ROC Curve Surgical Oncology Time Factors Triglycerides - blood |
SummonAdditionalLinks | – databaseName: SpringerLINK - Czech Republic Consortium dbid: AGYKE link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1ra9RAcNAriF98P1KrrCAISkqSfWT34yGtRal-aaF-Cvs6PDxy5S7XD_76zuRl71ChX0LCzm72MTM7szM7A_CuwE0jWCTAGaIDKihOplrwkBqy-kWXGe_paOD0mzo5F18u5EV_j3s9eLsPJsmWU4-X3dpQJGmbjaAsVcrvwp7MtdET2Jt-_vH16I_xIGvTcqLiItIcJe7BmPm3Rra2o12mfGNX2jGTtrvP8UM4G_rdOZ38Otw07tD_3gnpeMuBPYIHvTTKph36PIY7sX4C9057e_tTiN9XWEwcEj9Zs1xEysOBb9htZtfMsnp5FRf4rOf1lSVXeNblpGYoDLPLFbVEjtUEYbtsvHPPCLOa5c9I3tzNfP0Mzo-Pzj6dpH1ihtTLwjSp46XwERW3PDhrZk6VXAYTtcpmOhTah6iklVpLpbVHiQ7FSMell8GVWhYq8Ocwwd_Gl8CidkIYOkrB1ZLa2MBV9CF4H2TmsyyBbFifyvdRyyl5xqIa4y2301fh9FU0fRVP4MNY5bIL2fE_4Pe06BWRM7brbX8rAXtHgbGqaZmTJTkXRQIHW5BIhn67eECbqmcDa9SrjEadGnX0BN6OxVSTXNvquNy0MAalcqFEAi86dBu7XXCK1sPLBD4OqHOj8X-Naf9W0K_gPgqBovNEP4BJs9rE1yhoNe5NT1jX5u8baQ priority: 102 providerName: Springer Nature |
Title | Oral choline tolerance test as a novel noninvasive method for predicting nonalcoholic steatohepatitis |
URI | https://link.springer.com/article/10.1007/s00535-013-0776-3 https://www.ncbi.nlm.nih.gov/pubmed/23503837 https://www.proquest.com/docview/1498210402 https://www.proquest.com/docview/1499150464 |
Volume | 49 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED_aBsZeytZ91FsXNBgMNswcS7LlhzGSkaxsNBtjgezJ6Cs0EOwscfv3784faVNoX5IYybJyvjv9Tne6A3gX46LhNArgAtkBDRQjQyW4CzPy-nkTZdbS1sDFNDmfie9zOT-AaXcWhsIqO51YK2pXWtoj_4RIXqF5gubOl_W_kKpGkXe1K6Gh29IK7nOdYuwQeqiSFfJ9bzSe_vp941eI6oqdaNOIcIBgvPNzRnVaUckpkI2HlOIm5Hsr1V19fWvBuuNBrRemyRM4bhElGzYs8BQOfHECjy5an_kz8D832ExaDi9ZVa481dLAXzg-01umWVFe-xV-FsviWlM4O2vqSjMEtGy9oZEoOJp66Kai7tIy4o6qvPQUkV0tt89hNhn_-XoetsUVQivjrAoNT4X1aHwNnNHZwiQply7zKokWysXKOp9ILZWSiVIWURlCQcOllc6kSsaJ4y_gCB_rT4F5ZYTIaDsEySpVph1PvHXOWicjG0UBRB0hc9tmHqcCGKt8lzO5pn2OtM-J9jkP4MPulnWTduOhzu_p7eQkkjiu1e3JApwdJbfKh-mAvMEDEQdwttcTRcnuN3fvN29FeZvfMF4Ab3fNdCeFpxW-vKr7ZIisRSICeNnwxW7aMaeMOzwN4GPHKLcGv-8_vXp4Kq_hMSI30YSPn8FRtbnybxAdVaYPh-k87UNvOBmNpvT97e-Pcb8VBGydxcP_3lANeA |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9Mw8DQ6CXhBfBMYYCQQEigije3EeZjQgE0dWwtCm7Q3z7FdrVKVdG02xJ_jt3GXj26dxN72EiWyc3HO5_vwne8A3sYoNJzBBThGckADJZehEtyFGXn9fB5l1tLWwHCUDA7F9yN5tAZ_u7MwFFbZ8cSaUbvS0h75J9TkFZonaO58np2GVDWKvKtdCQ3TllZwm3WKsfZgx57_8xtNuMXm7jec73dxvLN98HUQtlUGQivjrApzngrr0Qrpu9xk4zxJuXSZV0k0Vi5W1vlEGqmUTJSyqJ6gTpRzaaXLUyXjxHGEewvWBZ1w7cH6l-3Rz18XfoyorhCKNpQI-6j8d37VqE5jKjkFzvGQUuqEfEUyXpUPlwTkFY9tLQh37sO9VoNlWw3JPYA1XzyE28PWR_8I_I85NhNXxUdWlVNPtTvwDuEzs2CGFeW5n-K1mBTnhsLnWVPHmqECzWZzgkTB2NTDNBV8J5YRNVbliacI8GqyeAyHN4LmJ9DDz_pnwLzKhcho-wXRKlVmHE-8dc5aJyMbRQFEHSK1bTOdU8GNqV7maK5xrxH3mnCveQAflq_MmjQf13V-T7OjiQUgXGvakww4OkqmpbfSPnmf-yIOYGOlJy5du9rcza9uWcdCXxB6AG-WzfQmhcMVvjyr-2SoyYtEBPC0oYvlsGNOGX54GsDHjlAuAf_fPz2_fiiv4c7gYLiv93dHey_gLmqNogld34BeNT_zL1Ezq_JXLfkzOL7pFfcP-StE0w |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9QwzBpDmnhBjM_CNoIEQgJVyzVJmz6gaWKcNsYGD0y6t9B8nDjp1B533RB_jV-H3Y_bbhJ720vVKombOnZsx64N8DpBoeELZMAxkgMaKFbFWgof5-T1C5bnztHRwMlpengmP4_UaA3-9v_CUFhlvyc2G7WvHJ2R76Imr9E8QXNnd9yFRXw7GO7NfsVUQYo8rX05jZZEjsOf32i-LT4cHeBav0mS4afvHw_jrsJA7FSS17EVmXQBLZCBt0U-tmkmlM-DTvlY-0Q7H1JVKK1VqrVD1QT1ISuUU95mWiWpFwj3DtzFUZwMv2yUXXoweFMbFK0nGQ9Q7e89qrxJYKoEhcyJmJLpxGJFJl6XDFdE4zVfbSMChw_gfqe7sv2W2DZhLZQPYeOk884_gvB1js20n-Ijq6tpoKodeIfwWbFgBSurizDFazkpLwoKnGdtBWuGqjObzQkShWFTj6Kt3TtxjOiwrn4Giv2uJ4vHcHYrSH4C6_ja8AxY0FbKnA5eEK1K54UXaXDeO-cVd5xHwHtEGtflOKdSG1OzzM7c4N4g7g3h3ogI3i2HzNoEHzd1fkurY4j5Ea4run8YcHaURsvsZwPyOw9kEsHWSk9kWrfa3K-v6TaNhbkk8QheLZtpJAXClaE6b_rkqMPLVEbwtKWL5bQTQbl9RBbB-55QrgD_3zc9v3kqL2ED-cx8OTo9fgH3UF2Ubcz6FqzX8_OwjSpZbXca2mfw47aZ7R_v60Jp |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oral+choline+tolerance+test+as+a+novel+noninvasive+method+for+predicting+nonalcoholic+steatohepatitis&rft.jtitle=Journal+of+gastroenterology&rft.au=Imajo%2C+Kento&rft.au=Yoneda%2C+Masato&rft.au=Fujita%2C+Koji&rft.au=Kessoku%2C+Takaomi&rft.date=2014-02-01&rft.eissn=1435-5922&rft.volume=49&rft.issue=2&rft.spage=295&rft_id=info:doi/10.1007%2Fs00535-013-0776-3&rft_id=info%3Apmid%2F23503837&rft.externalDocID=23503837 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0944-1174&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0944-1174&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0944-1174&client=summon |